# Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia

> **NCT02141412** · PHASE4 · COMPLETED · sponsor: **American University of Beirut Medical Center** · enrollment: 216 (actual)

## Conditions studied

- Anesthesia Recovery
- Anesthesia Emergence
- Shivering
- Postoperative Recovery

## Interventions

- **DRUG:** dexmedetomidine 0.25 µg/kg IV
- **DRUG:** dexmedetomidine 0.5 µg/kg IV
- **DRUG:** dexmedetomidine 1 µg/kg IV
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT02141412
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141412, "Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02141412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*